RYCFX Mutual Fund

RYCFX Mutual Fund (Rydex Biotechnology Fund Class C) is managed by Rydex Funds with $413,103.41 in net assets. RYCFX expense ratio is 2.38%, holding 75 positions across sectors including Health Care. Inception date: 2001-03-30.

RYCFX performance shows a YTD return of 14.54%. The 1-year return is 45.96% and the 5-year return is 4.67%. RYCFX dividend yield stands at 18.98%, paid annually.

RYCFX top holdings include Abbvie Inc. (7.4%), Amgen Inc. (5.2%), Gilead Sciences (5.0%), Nvaesrtex Pharmaceuticals Inc (4.0%), Regeneron Pharmaceuticals, Inc. (3.6%). Go to all RYCFX holdings, RYCFX sectors, or RYCFX dividends.

RYCFX can be compared against other funds. Use RYCFX overlap to find shared positions, or RYCFX vs another fund for a side-by-side view. RYCFX alternatives are available via the screener, along with tax-loss harvesting opportunities.